In a subsequent study, we demonstrated that KRAS activation promotes epithelial to mesenchymal transition (EMT) and acquisition of cancer stem-like cell (CSC) phenotypes, including metastatic potential and chemoresistance [7]. Here, KRAS is linked to cancer.